Literature DB >> 6335802

T cell-macrophage interaction in arginase-mediated resistance to herpes simplex virus.

L Bonina, A A Nash, A Arena, K N Leung, P Wildy.   

Abstract

Peritoneal macrophages activated by-products derived from a herpes simplex virus-specific helper T cell clone were used to investigate intrinsic and extrinsic resistance mechanisms to herpes simplex virus type 1 infection in vitro. T cell-activated macrophages produced fewer infective centres, indicating enhanced intrinsic resistance, and markedly reduced the growth of virus in a permissive cell line. The reduction in virus growth correlated with the depletion of arginine in the support medium, presumably resulting from increased arginase production by activated macrophages. The significance of these findings for antiviral immunity in vivo is discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6335802     DOI: 10.1016/0168-1702(84)90007-8

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  4 in total

1.  CD8+ T cells suppress viral replication in the cornea but contribute to VEGF-C-induced lymphatic vessel genesis.

Authors:  Christopher D Conrady; Min Zheng; Donald U Stone; Daniel J J Carr
Journal:  J Immunol       Date:  2012-05-30       Impact factor: 5.422

2.  Role of CD8+ T cells and lymphoid dendritic cells in protection from ocular herpes simplex virus 1 challenge in immunized mice.

Authors:  Harry Matundan; Kevin R Mott; Homayon Ghiasi
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

Review 3.  Immunological aspects of acute and recurrent herpes simplex keratitis.

Authors:  Jacek Rolinski; Iwona Hus
Journal:  J Immunol Res       Date:  2014-09-07       Impact factor: 4.818

4.  Role of TH17 Responses in Increasing Herpetic Keratitis in the Eyes of Mice Infected with HSV-1.

Authors:  Satoshi Hirose; Ujjaldeep Jaggi; Shaohui Wang; Kati Tormanen; Yoshiko Nagaoka; Makoto Katsumata; Homayon Ghiasi
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-06-03       Impact factor: 4.799

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.